These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 25883247)

  • 1. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
    Deng XF; Liu QX; Zhou D; Min JX; Dai JG
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.
    Kelsey CR; Higgins KA; Peterson BL; Chino JP; Marks LB; D'Amico TA; Varlotto JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):768-773.e1. PubMed ID: 23856204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis.
    Deng XF; Jiang L; Liu QX; Zhou D; Hou B; Cui K; Min JX; Dai JG
    J Cardiothorac Surg; 2016 Feb; 11():28. PubMed ID: 26883746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence in patients with resected N1 non-small cell lung cancer - a systematic review and meta-analysis.
    Luo H; Qiao L; Liang N; Zhang J
    J BUON; 2015; 20(3):791-9. PubMed ID: 26214632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
    Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
    Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of relationship between lymph node micrometastasis and prognosis in stage I non-small cell lung cancer patients].
    Zheng Z; Pan TC; Li J; Chen T; Song DW; Yi J
    Ai Zheng; 2004 Feb; 23(2):185-8. PubMed ID: 14960241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis.
    Hsu CP SL; Chen CY; Kwang PC; Miao J; Hsia JY; Shai SE
    Eur J Surg Oncol; 2000 Nov; 26(7):691-5. PubMed ID: 11078616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer.
    Hüyük M; Fiocco M; Postmus PE; Cohen D; von der Thüsen JH
    Histopathology; 2023 Apr; 82(5):650-663. PubMed ID: 36282087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
    Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.